0000939798-19-000008.txt : 20190319
0000939798-19-000008.hdr.sgml : 20190319
20190319143804
ACCESSION NUMBER: 0000939798-19-000008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190201
FILED AS OF DATE: 20190319
DATE AS OF CHANGE: 20190319
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Urbanski Raymond W.
CENTRAL INDEX KEY: 0001653096
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-08092
FILM NUMBER: 19691181
MAIL ADDRESS:
STREET 1: 28903 NORTH AVENUE PAINE
CITY: VALENCIA
STATE: CA
ZIP: 91355
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: GT Biopharma, Inc.
CENTRAL INDEX KEY: 0000109657
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 941620407
STATE OF INCORPORATION: FL
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 310 N. WESTLAKE BLVD.
STREET 2: SUITE 206
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
BUSINESS PHONE: (800) 304-9888
MAIL ADDRESS:
STREET 1: 310 N. WESTLAKE BLVD.
STREET 2: SUITE 206
CITY: WESTLAKE VILLAGE
STATE: CA
ZIP: 91362
FORMER COMPANY:
FORMER CONFORMED NAME: OXIS INTERNATIONAL INC
DATE OF NAME CHANGE: 19940916
FORMER COMPANY:
FORMER CONFORMED NAME: DDI PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: DIAGNOSTIC DATA INC /DE/
DATE OF NAME CHANGE: 19850312
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2019-02-01
0
0000109657
GT Biopharma, Inc.
GTBP
0001653096
Urbanski Raymond W.
26950 ALSACE DR.
CALABASAS
CA
91302
1
1
0
0
CEO
common stock
2019-02-01
4
S
0
176980
0.001
D
1351918
D
The disposal of the 176,980 shares was made to satisfy obligations pursuant to the terms of a Stock Pledge Agreement signed on August 1, 2018.
/s/ Raymond W Urbanski
2019-03-19